Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Pharmaceutical Cannabidiol in Pediatric Treatment-Resistant Seizures
NCT02324673Phase 2Completed
- Sponsor
- Insys Therapeutics
- Start
- Apr 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in epilepsy, sponsored by Insys Therapeutics. Started Apr 2015; status: completed.
02
Drugs
cannabidiol
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02324673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02324673.